StockNews.com Initiates Coverage on Athersys (NASDAQ:ATHX)

StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX) in a report issued on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.

Athersys Price Performance

ATHX stock opened at $0.00 on Friday. The stock has a market capitalization of $191,328.90, a P/E ratio of 0.00 and a beta of -0.90. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99.

Athersys Company Profile

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.